Abstract
Viruses are considered as key environmental factors that may cause inflammatory arthritis and autoimmune diseases in genetically susceptible hosts. Viruses can elicit acute or subacute and, less often, chronic forms of arthritis. These viral arthritis syndromes can be diagnosed by recognition of well-defined clinical signs and detection of viral antibodies and nucleic acids. Moreover, viral elements may also play a role in the pathogenesis of idiopathic autoimmune rheumatic diseases. The concordance rate of the most common autoimmune disease, such as rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE), in monozygotic twins is about 25% (1). Although these data show that genetic factors influence susceptibility to autoimmune diseases, alternatively, a 70% discordance rate emphasizes the importance of environmental factors. Forensic studies of archeological sites revealed the presence of RA-like erosive bony changes in pre-Columbian New World populations dating back 6500 yr and the absence of RA in the Old World before the 18th century (2). This geographic distribution suggest that RA may have spread from the Americas through environmental factors, possibly by a virus, another microorganism, or an antigen. The potential etiological role of viruses in chronic rheumatic diseases have been recently reviewed (3).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arnett, F. C. and Reveille, J. D. (1992) Genetics of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 18, 865–892.
Rothschild, B. M., Woods, R. J., Rothschild, C., and Sebes, J. I. (1992) Geographic distribution of rheumatoid arthritis in ancient North America: implications for pathogenesis. Semin. Arthritis Rheum. 22, 181–187.
Inman, R. D., Perl, A., and Phillips, P. E. (1997) Infectious agents in chronic rheumatic diseases, in Arthritis and Allied Conditions. A Textbook of Rheumatology. (Koopman, W. J., ed.), Lea & Febiger, Philadelphia, p. 585.
Naides, S. J. (1998) Rheumatic manifestations of parvovirus B19 infection [Review]. Rheum. Dis. Clin. North Am. 24, 375–401.
Takahashi, Y., Murai, C., Shibata, S., Munakata, Y., Ishii, T., Ishii, K., et al. (1998) Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 95, 8227–8232.
Soderlund, M., von Essen, R., Haapasaari, J., Kiistala, U., Kiviluoto, O., and Hedman, K. (1997) Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy [see comments]. Lancet 349, 1063–1065.
Phillips, P. E. (1997) Viral arthritis. Curr. Opin. Rheumatol. 9, 337–344.
Tingle, A. J., Mitchell, L. A., Grace, M., Middleton, P., Mathias, R., and MacWilliam, L. (1997) Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 349, 1277–1281.
Ray, P., Black, S., Shinefield, H., Dillon, A., Schwalbe, J., Holmes, S., et al. (1997) Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team [see comments]. JAMA 278, 551–556.
Frenkel, L. M., Nielsen, K., Garakian, A., Jin, R., Wolinsky, J. S., and Cherry, J. D. (1996) A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clin. Infect. Dis. 22, 287–294.
Gordon, S. C. and Lauter, C. B. (1984) Mumps arthritis: a review of the literature. Rev. Infect. Dis. 6, 338–344.
Zhang, D., Nikkari, S., Vainionpaa, R., Luukkainen, R., Yli-Kerttula, U., and Toivanen, P. (1997) Detection of rubella, mumps, and measles virus genomic RNA in cells from synovial fluid and peripheral blood in early rheumatoid arthritis. J. Rheumatol. 24, 1260–1265.
Espinoza, L. R. and Cuellar, M. L. (1998) Retrovirus-associated rheumatic syndromes, in Arthritis and Allied Conditions. (Koopman, W. J., ed.), Williams & Wilkins, Baltimore, p. 2361.
Le Goff, P., Chicault, P., Saraux, A., Baron, D., Valls-Bellec, I., and Leroy, J. P. (1998) Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus. Rev. D Rhumatisme, Eng. Ed. 65, 283–286.
Vassilopoulos, D., Waltuck, J., Clarke, G., Farhi, D. C., Williams, J., and Fanucchi, M. P. (1998) Reversible Epstein-Barr virus associated T cell non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis undergoing chronic immunosuppressive therapy. J. Rheumatol. 25, 389–391 (letter).
Natkunam, Y., Elenitoba-Johnson, K. S., Kingma, D. W., and Kamel, O. W. (1997) EpsteinBarr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. Arthritis Rheum. 40, 1152–1156.
Paul, C., Le Tourneau, A., Cayuela, J. M., Devidas, A., Robert, C., and Molinie, V. (1997) Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch. Dermatol. 133, 867–871.
Stebbings, S., Highton, J., Croxson, M. C., Powell, K., McKay, J., and Rietveld, J. (1998) Chickenpox monoarthritis: demonstration of varicella-zoster virus in joint fluid by polymerase chain reaction. Br. J. Rheumatol. 37, 311–313.
Ferri, C., La Civita, L., Longombardo, G., Zignego, A. L., and Pasero, G. (1998) Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 7, 275–279.
Ferri, C., Greco, F., Longombardo, G., Palla, P., Moretti, A., Marzo, E., et al. (1991) Association between hepatitis C virus and mixed cryoglobulinemia. Clin. Exp. Rheumatol. 9, 621–624.
Agnello, V., Chung, R. T., and Kaplan, L. M. (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327, 1490–1495.
Gorevic, P. D., Kassab, H. J., Levo, Y., Kohn, R., Meltzer, M., Prose, P., et al. (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am. J. Med. 69, 287–308.
Perl, A., Gorevic, P. D., Ryan, D. H., Condemi, J. J., Ruszkowski, R. J., and Abraham, G. N. (1989) Clonal B cell expansions in patients with essential mixed cryoglobulinaemia. Clin. Exp. Immunol. 76, 54–60.
Ferri, C., Monti, M., La Civita, L., Longombardo, G., Greco, F., Pasero, G., et al. (1993) Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82, 3701–3704.
Akriviadis, E. A., Xanthakis, I., Navrozidou, C., and Papadopoulos, A. (1997) Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J. Clin. Gastroenterol. 25, 612–618.
Nishioka, K. (1996) HTLV-I arthropathy and Sjogren syndrome. J. Acquired Immune Deficiency Syndromes Hum. Retrovirol. 13(Suppl. 1), S57–S62.
Paxton, W. A., Dragic, T., Koup, R. A., and Moore, J. P. (1996) The β-chemokines, HIV type 1 second receptors, and exposed uninfected persons. AIDS Res. Hum. Retrovirus 12, 1203–1207.
Weitzul, S., and Duvic, M. (1997) HIV-related psoriasis and Reiter’s syndrome [Review]. Semin. Cutan. Med. Surg. 16, 213–218.
Carpenter, A. B. (1997) Enzyme-linked Immunoassays, in Manual of Clinical and Laboratory Immunology, 5th ed., (Rose, N. R., Conway de macario, E., Folds, J. D., Lane, H. C., and Nakamura, R. N., eds.), ASM, Washington, DC, pp. 22–29.
McCallum, R. M., Patel, D. D., Moore, J. O., and Haynes, B. F. (1997) Arthritis syndromes associated with human T cell lymphotropic virus type I infection [Review]. Med. Clin. North Am. 81, 261–276.
Podzorski, R. P., Kukuruga, D. L., and Long, P. M. (1997) Introduction to molecular methodology, in Manual of Clinical Laboratory Immunology (Rose, N. R., Conway de macario, E., Folds, J. D., Lane, H. C., and Nakamura, R. N., eds.), ASM, Washington, pp. 77–107.
Rich, S. A. (1981) Human lupus inclusions and interferon. Science 213, 772–775.
Stransky, G., Vernon, J., Aicher, W. K., Moreland, L. W., and Gay, R. E. (1993) Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br. J. Rheumatol. 32, 1044–1048.
Mellors, R. C. and Mellors, J. W. (1978) Type C RNA virus-specific antibody in human SLE demonstrated by enzymoimmunoassay. Proc. Natl. Acad. Sci. USA 75, 2463–2467.
Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P. M., and Miedema, F. (1992) Programmed death of T cells in HIV infection. Science 257, 217–219.
Emlen, W., Niebur, J. A., and Kadera, R. (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152, 3685–3692.
McGuinnis, M. H., Macher, A. H., and Rook, A. H. (1996) Red cell autoantibodies in patients with AIDS. Transfusion 26, 405–409.
Geissler, R. G., Rossol, R., Mentzel, U., Ottmann, O. G., Klein, A. S., Gute, P., et al. (1996) Gamma delta-T cell-receptor positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type I-infected patients. AIDS Res. Hum. Retrovirus 12, 577–584.
Karpatkin, S. (1990) HIV-1-related thrombocytopenia. Hematol. Oncol. Clin. North Am. 4, 193–218.
Dalakas, M. C., Pezeshkpour, G. H., Gravell, M., and Sever, J. L. (1986) Polymyositis associated with AIDS retrovirus. JAMA 256, 2381–2383.
Calabrese, L. (1989) The rheumatic manifestations of infection with the HIV. Semin. Arthritis Rheum. 18, 225–239.
Hicks, J. T., Aulakh, G. S., McGrath, P. P., Washington, G. C., Kim, E., and Alepa, F. P. (1979) Search for Epstein—Barr and type C oncornaviruses in systemic lupus erythematosus. Arthritis Rheum. 22, 845–857.
Yoshiki, T., Mellors, R. C., Strand, M., and August, J. T. (1974) The viral envelope glycoprotein of murine leukemia virus and the pathoegenesis of immune complex glomerulonephritis of New Zealand mice. J. Exp. Med. 140, 1011–1025.
Krieg, A. M. and Steinberg, A. D. (1990) Analysis of thymic endogenous retroviral expression in murine lupus. J. Clin. Invest. 86, 809–816.
Krieg, A. M., Gourley, M. F., and Perl, A. (1992) Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J. 6, 2537–2544.
Banki, K., Maceda, J., Hurley, E., Ablonczy, E., Mattson, D. H., Szegedy, L., et al. (1992) Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc. Natl. Acad. Sci. USA 89, 1939–1943.
Perl, A., Colombo, E., Dai, H., Agarwal, R. K., Mark, K. A., Banki, K., et al. (1995) Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum. 38, 1660–1671.
Brookes, S. M., Pandolfino, Y. A., Mitchell, T. J., Venables, T. J. W., Shattles, W. G., Clark, D. A., et al. (1992) The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br. J. Rheumatol. 31, 735–742.
Bengtsson, A., Blomberg, J., Nived, O., Pipkorn, R., Toth, L., and Sturfelt, G. (1996) Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum. 39, 1654–1663.
Li, J., Fan, W. S., Horsfall, A. C., Anderson, A. C., Rigby, S., Larsson, E., et al. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin. Exp. Immunol. 104, 388–393.
Oldstone, M. B. A. (1987) Molecular mimicry and autoimmune disease. Cell 50, 819–820.
Baum, H., Davies, H., and Peakman, M. (1996) Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol. Today 17, 64–70.
Albani, S. and Carson, D. A. (1996) A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol. Today 17, 466–470.
Reichlin, M. (1994) Antibodies to ribonuclear proteins. Rheum. Dis. Clin. North Am. 20, 29–43.
Query, C. C. and Keene, J. D. (1987) A human autoimmune protein associated with U 1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 51, 211–220.
Perl, A., Rosenblatt, J. D., Chen, I. S., DiVincenzo, J. P., Bever, R., Poiesz, B. J., et al. (1989) Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acids Res. 17, 6841–6854.
Sela, M. (1969) Antigenicity: some molecular aspects. Science 166, 1365–1374.
Talal, N., Garry, R. F., Schur, P. H., Alexander, S., Dauphinee, M. J., Livas, I. H., et al. (1990) A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J. Clin. Invest. 85, 1866–1871.
Sabbatini, A., Bombardieri, S., and Migliorini, P. (1993) Autoantibodies form patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur. J. Immunol. 23, 1146–1152.
Vaughan, J. H., Valbracht, J. R., Nguyen, M., Handley, H. H., Smith, R. S., Patrick, K., et al. (1995) Epstein-Barr virus-induced autoimmune responses I. Immunoglobulin M autoantibodies to mimicking and nonmimicking Epstein-Barr virus nuclear antigen-1. J. Clin. Invest. 95, 1306–1315.
Vaughan, J. H., Nguyen, M., Valbracht, J. R., Patrick, K., and Rhodes, G. H. (1995) Epstein—Barr virus-induced autoimmune responses II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J. Clin. Invest. 95, 1316–1327.
Steinberg, A. D., Gourley, M. F., Klinman, D. M., Tsokos, G. C., Scott, D. E., and Krieg, A. M. (1991) Systemic lupus erythematosus. Ann. Intern. Med. 115, 548–559.
James, J. J., Kaufman, K. M., Farris, A. D., Taylor-Albert, E., Lehman, T. J. A., and Harley, J. B. (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100, 3019–3026.
Misaki, Y., Yamamoto, K., Yanagi, K., Miura, H., Ichijo, H., Kato, T., et al. (1993) B cell epitope on the U 1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein. Eur. J. Immunol. 23, 1064–1071.
Phillips, P. E., Johnston, S. L., Runge, L. A., Moore, J. L., and Poiesz, B. J. (1986) High IgM antibody to human T-cell leukemia virus type I in systemic lupus erythematosus. J. Clin. Immunol. 6, 234–241.
Kohsaka, H., Yamamoto, K., Fujii, H., Miura, H., Miyasaka, N., Nishioka, K., et al. (1990) Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. J. Clin. Invest. 85, 1566–1574.
Perl, A. and Banki, K. (1993) Human endogenous retroviral elements and autoimmunity: data and concepts. Trends Microbiol. 1, 153–156.
Zhu, Z. B., Hsieh, S., Bentley, D. R., Campbell, D., and Volanakis, J. E. (1992) A variable number of tandem repeat locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J. Exp. Med. 175, 1783–1787.
Watanabe-Fukunaga, R., Brannan, C. L., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317.
Nagata, S. and Golstein, P. (1995) The Fas death factor. Science 267, 1449–1456.
Cianciolo, G. J., Copeland, T. D., Oroszlan, S., and Snyderman, R. (1985) Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230, 453–455.
Haraguchi, S., Good, R. A., and Day, N. K. (1995) Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16, 595–603.
Harley, J. B. and Gaither, K. K. (1988) Autoantibodies in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 14, 43–56.
Dayal, A. K. and Kammer, G. M. (1996) The T cell enigma in lupus. Arthritis Rheum. 39, 23–33.
Tsokos, G. C. (1992) Overview of cellular immune function in systemic lupus erythematosus, in Systemic Lupus Erythematosus (Lahita, R. G., ed.), Churchill Livingstone, New York, p. 15.
Klinman, D. M. and Steinberg, A. D. (1995) Inquiry into murine and human lupus. Immunol. Rev. 144, 157–193.
Clerici, M. and Shearer, G. M. (1994) The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15, 575–581.
Casciola-Rosen, L. A., Anhalt, G., and Rosen, A. (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317–1330.
Cohen, J. J., Duke, R. C., Fadok, V. A., and Sellins, K. S. (1992) Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol. 10, 267–293.
White, E., Cipriani, R., Sabbatini, P., and Denton, A. (1991) The adenovirus E 1 B 19-kilodalton protein overcomes the cytotoxicity of E 1 A proteins. J. Virol. 65, 2968–2978.
Whyte, P., Buchkovich, K., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., et al. (1988) Association between and oncogene and an anti-oncogene: the adenovirus E 1 A proteins bind to the retinoblastoma gene product. Nature 334, 124–129.
Pan, H. and Griep, A. E. (1995) Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dey. 9, 2157–2169.
Ehret, A., Westendorp, M. O., Herr, I., Debatin, K., Heeney, J. L., Frank, R., et al. (1996) Resistance of chimpanzee T cells to human immunodeficiency virus type I tat-enhanced oxidative stress and apoptosis. J. Virol. 70, 6502–6507.
Banki, K., Hutter, E., Gonchoroff, N. J., and Perl, A. (1998) Molecular ordering in HIV-induced apoptosis: oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J. Biol. Chem. 273, 11,944–11,953.
Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., et al. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp 120. Nature 375, 497–500.
Strack, P. R., Frey, M. W., Rizzo, C. J., Cordova, B., George, H. J., Meade, R., et al. (1996) Apoptosis mediated by HIV protease is proceeded by cleavage of bcl-2. Proc. Natl. Acad. Sci. USA 93, 9571–9576.
Morey, A. L., Ferguson, D. J, and Fleming, K. A. (1993) Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence for cell death by apoptosis. J. Pathol. 169, 213–220.
Naides, S. J., Scharosch, L. L., Foto, F., and Howard, E. J. (1990) Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum. 33, 1297–1309.
Hinshaw, V. S., Olsen, C. W., Dybdahl-Sissoko, N., and Evans, D. (1994) Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68, 3667–3673.
Bargonetti, J., Reynisdottir, I., Friedman, P. N., and Prives, C. (1992) Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dey. 6, 1886–1898.
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136.
Wang, X. W., Gibson, M. K., Vermeulen, W., Yeh, H., Forrester, K., Sturzbecher, H. W., et al. (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55, 6012–6016.
Bartz, S. R., Rogel, M. E., and Emerman, M. (1996) Human immunodeficiency virus type 1 cell cycle control: vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70, 2324–2331.
Planelles, V., Jowett, J. B. M., Li, Q., Xie, Y., Hahn, B., and Chen, I. S. Y. (1996) Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70, 2516–2524.
He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., and Landau, N. R. (1995) Human immunodeficiency virus type 1 viral protein R (vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705–6711.
Rao, L., Debbas, M., Sabbatini, P., Hockenberry, D., Korsmeyer, S., and White, E. (1992) The adenovirus E1 A proteins induce apoptosis which is inhibited by the E 1 B 19K and bc1–2 proteins. Proc. Natl. Acad. Sci. USA 89, 7742–7746.
Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., and Rickinson, A. (1993) Epstein—Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90, 8479–8483.
Neilan, J. G., Lu, Z., Afonzo, C. L., Kutish, G. F., Sussman, M. D., and Rock, D. L. (1993) An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the EpsteinBarr virus gene BHRF1. J. Virol. 67, 4391–4394.
Chou, J. and Roizman, B. (1992) The gamma1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 89, 3266–3270.
Yamada, T., Yamaoka, S., Goto, T., Nakai, M., Tsujimoto, Y., and Hatanaka, M. (1994) The human T-cell leukemia virus type I tax protein induces apoptosis which is blocked by the bcl-2 protein. J. Virol. 68, 3374–3379.
Masutani, H., Hirota, K., Sasada, T., Ueda-Taniguchi, Y., Taniguchi, Y., Sono, H., et al. (1996) Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I tax. Immunol. Lett. 54, 67–71.
Kishi, S., Saijyo, S., Arai, M., Karasawa, S., Ueda, S., Kannagi, M., et al. (1997) Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J. Exp. Med. 186, 57–64.
Iwakura, Y., Tosu, M., Yoshida, E., Takiguchi, M., Sato, K., Kitajima, I., et al. (1991) Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253, 1026–1028.
Green, J. E., Hinrichs, S. H., Vogel, J., and Jay, G. (1989) Exocrinopathy resembling Sjögren’s syndrome in HTLV-I tax transgenic mice. Nature 341, 72–74.
Banki, K., Hutter, E., Colombo, E., Gonchoroff, N. J., and Perl, A. (1996) Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 271, 32,994–33,001.
Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S., et al. (1992) Viral inhibition of inflammation; cowpox virus encodes an inhibitor of the interleukein- l β converting enzyme. Cell 69, 597–604.
Thome, M., Schneider, P., Hofman, K., Fickenscher, H., Meinl, E., Neipel, F., et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517–521.
Bertin, J. (1997) Death effector domain-containing herpesvirus and poxvirus proteins inhibit Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172–1176.
Hochberg, M. C. (1990) Systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 16, 617–639.
Ray, C. G., Gall, E. P., Minnich, L. L., Roediger, J., De Benedetti, C., and Corrigan, J. J. (1982) Acute polyarthritis associated with active Epstein-Barr virus infection. JAMA 248, 2990–2993.
Friedman, H. M., Pincus, T., Gibilisco, P., Baker, D., Glazer, J. P., and Plotkin, S. A. (1980) Acute monoarticular arthritis caused by herpes simplex virus and cytomegalovirus. Am. J. Med. 69, 241–247.
Remafedi, G. and Muldoon, R. L. (1983) Acute monarticular arthritis caused by herpes simplex virus type. Pediatrics 72, 882,883.
Sato, K., Maruyama, I., Maruyama, Y., Kitajima, I., Nakajima, Y., Higaki, M., et al. (1991) Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. Arthritis Rheum. 34, 714–721.
Clem, R. J. and Miller, L. K. (1994) Control of programmed cell death by the baculovirus genes p35 and iap. Mol. Cell. Biol. 14, 5212–5222.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Perl, A. (2000). Viruses. In: Tsokos, G.C. (eds) Principles of Molecular Rheumatology. Current Molecular Medicine, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-018-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-018-6_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-182-0
Online ISBN: 978-1-59259-018-6
eBook Packages: Springer Book Archive